Cell-Based Assays

SMi is pleased to announce its third annual conference on Cell-Based Assays, due to take place in London on Monday 22nd and Tuesday 23rd November 2010. About the conference Now that the majority of screening assays employ the use of cell-based technologies, robust cell-based assays are essential for lead identification and the optimisation of therapeutic candidates. Factors including the ever increasing numbers of compound failures and rapidly escalating costs of R&D are driving the uptake of increasingly biologically relevant surrogates in cell-based assays to predict the response of drug candidates - leading to developments in areas including stem cell use in screening programmes, 3D cell cultures and label-free detection. These technologies, and the effective techniques and methods employed in their use have been progressing at breakneck speed and this conference will assemble leading experts from both industry and academia to present you with the latest updates, technologies and critical strategies in a practical, case study focused environment. Hear about new techniques, technologies and methods used in cell-based assays Discuss the use of stem cells in discovery and development Explore the powers of RNAi screening in target discovery and biomarker identification Learn from multiple case studies demonstrating real life data and processes that work Network with key industry associates and solution providers to share valuable experiences Why not attend the associated workshop as well? Associated with the conference there will be a half-day interactive workshop on "Cell-based assay preparation for high content analysis and troubleshooting strategies", taking place on 24th November.  It will cover an advanced look into cell based assay preparation for high content analysis and troubleshooting strategies. This will be led by Anthony Mitchell Davies, Director of the high content facility at Trinity College Dublin.  To see more information about the workshop, please see the workshop page.

Keen to see the detailed programme? Click here.

Want to download the brochure?  Click here.

Want to register your place? Click here.

Make a group booking - discounts apply

Hear keynote addresses from:

Who is chairing this event?

Day One Dame Julia Polak Faculty of Medicine, Regenerative Medicine Consortium Imperial College London

Day Two Anne Phelan Executive Director and Head of the Research Enabling Group Pfizer

Who is speaking at this event?

Our keynote speakers Stephen Rees Director, Screening and Compound Profiling GlaxoSmithKline Claudine Grépin Head of Assay Development & Screening Sanofi-Aventis Glyn Stacey Director of the UK Stem Cell Bank NIBSC

Our expert speakers Anders Damholt, Head of Target Validation, AstraZeneca Andreas Scheel, Director, Assay Development, (OSI) Prosidion Carmel Nanthakumar, Principle Scientist, GlaxoSmithKline Daniel Kassel, Vice President, Analytical Sciences and DMPK, Takeda San Diego Daniel Zicha, Head of Light Microscopy, Cancer Research UK Derek Trezise, Director, European Discovery Services, Essen BioScience Frank Verdonck, Senior Scientist, Team Leader Cell-Based Screening, Ablynx John Curnow, Institute of Biomedical Research, University of Birmingham John Westwick, President and CEO, Odyssey Thera Katharina Maniura, Head of Research Program Materials for Health and Performance, EMPA Laura DeForge, Senior Scientist, Assay & Automation Technology, Genentech Leo Price, Division of Toxicology, Leiden-Amsterdam Center for Drug Research, Leiden University Markus Schmitz, Research & Development in Cellular Analysis, Roche Diagnostics Oliver Nayler, Director, Head, Cardiovascular & Fibrosis Biology, Actelion Pharmaceuticals Pamela Tranter, Group Head, Automated Electrophysiology, Novartis Paula McArdle, Scientist, Assay Sciences and Screening Group, AstraZeneca Roderick Beijersbergen, Head NKI Robotics and Screening Center, The Netherlands Cancer Institute

See the full agenda

Who should attend?

Heads of Department, Directors, Managers, Team Leaders, Researchers and Scientists from:

Organisations represented at our previous Cell-Based Assays conferences have included:

Venue details

London Marriott Hotel Regent's Park 128 King Henry's Road  London NW3 3ST Phone: +44 (0)207 722 7711 begin_of_the_skype_highlighting              +44 (0)207 722 7711      end_of_the_skype_highlighting  Fax: +44 (0)207 586 5822  Sales: +44 (0)207 449 4412  Sales fax: +44 (0)207 722 5973  www.marriott.co.uk/Regents-Park

Ideally located with easy access to London's major motorways, the London Marriott Hotel Regents Park is set in the quiet suburbs of Swiss Cottage; close to Lords Cricket Ground, London Zoo and the chic bars and restaurants of St Johns Wood and Primrose Hill. The nearby tube station offers direct access to Wembley and the O2 Centre, Bond Street, Westminster and Canary Wharf on the Jubilee line.

The only luxury North London hotel in Swiss Cottage, the London Marriott Hotel Regents Park promises a delightful stay, offering spacious rooms graced by amenities both pampering and practical - from luxurious new bedding to wireless Internet access. A tempting choice of dining includes the vibrant flavours of Brasserie Centrale and the casual Chat's Cafe Bar. To stay fit, a well-equipped leisure club and indoor pool awaits.

Nearest train station:
West Hampstead, 1.9 km

Nearest underground station:
Swiss Cottage (Jubilee line), 0.5 km, 5 min walk